Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2008;52:205-206
Published online before print June 9, 2008, doi: 10.1161/HYPERTENSIONAHA.108.115402
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
52/2/205    most recent
HYPERTENSIONAHA.108.115402v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schiffrin, E. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schiffrin, E. L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
*Kidney Diseases
Related Collections
Right arrow Animal models of human disease
Right arrowRelated Article

(Hypertension. 2008;52:205.)
© 2008 American Heart Association, Inc.


Editorial Commentaries

The Flame That Lights the Fire

Oxidative Stress, Inflammation, and Renal Damage in Angiotensin II–Induced Hypertension

Ernesto L. Schiffrin

From the Hypertension and Vascular Research Unit, Lady Davis Institute for Medical Research and Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, Quebec, Canada.

Correspondence to Ernesto L. Schiffrin, Lady Davis Institute for Medical Research and Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, 3755 Côte Ste-Catherine Rd, #B-127, Montreal, Quebec, Canada H3T 1E2. E-mail ernesto.schiffrin@mcgill.ca


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Low-grade inflammation has acquired progressive recognition over the past few years as a mechanism for cardiovascular and renal damage. In hypertension, the activation of inflammatory mediators has been demonstrated in blood vessels, the heart, and the kidney in angiotensin (Ang) II–dependent models of hypertension, such as human angiotensinogen/human renin double transgenic rats1 and rats infused with Ang II,2 or in mineralocorticoid-induced hypertension.3

Both Ang II and endothelin-1 trigger an inflammatory process that participates in the mechanisms of hypertension. In a mouse model deficient in macrophages, the osteopetrotic mouse, Ang II- and endothelin-1–dependent hypertension were blunted together with oxidative stress generation, inflammatory mediator expression, vascular remodeling, and endothelial dysfunction.4,5 In human hypertension, inflammatory biomarkers, specifically C-reactive protein but also others, predict incident hypertension.6

Ang II exerts proinflammatory effects by stimulating redox-sensitive signaling cascades leading to mitogen-activated protein kinase activation, more specifically, p38 mitogen-activated protein kinase. Oxidative stress then stimulates inflammatory mediators, including nuclear factor {kappa}B and activator protein-1. These, in turn, trigger production of chemokines, such as monocyte chemoattractant peptide-1, involved in macrophage recruitment, and activation of proinflammatory and prothrombotic agents, such as plasminogen activator inhibitor-1, and adhesion molecules, such as vascular cell adhesion molecule-1 and intercellular adhesion molecule-1.7 These inflammatory actions may require the participation of T-lymphocytes, important mediators in Ang II–induced hypertension. Guzik et al8 have shown that mice lacking T and B cells (RAG-1–/– mice) have blunted hypertension and do not develop abnormalities of vascular function during Ang II infusion or exposure to deoxycorticosterone acetate-salt, changes that are . . . [Full Text of this Article]


Related Article:

Role of Inflammation in the Development of Renal Damage and Dysfunction in Angiotensin II–Induced Hypertension
Tang-Dong Liao, Xiao-Ping Yang, Yun-He Liu, Edward G. Shesely, Maria A. Cavasin, William A. Kuziel, Patrick J. Pagano, and Oscar A. Carretero
Hypertension 2008 52: 256-263. [Abstract] [Full Text] [PDF]